Journal of Clinical Microbiology, January 1999, p. 39-44, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Laboratory of Microbiology, The Rockefeller University, New York, New York 10021,1 and The New York Hospital-Cornell Medical Center, New York, New York 100212
Received 20 July 1998/Returned for modification 31 August 1998/Accepted 21 October 1998
Methicillin-resistant Staphylococcus epidermidis (MRSE)
was recovered over a 2-month period from the dialysis fluid of a
peritoneal dialysis (PD) patient who experienced recurrent episodes of
peritonitis during therapeutic and prophylactic use of vancomycin.
Characterization of five consecutive MRSE isolates by molecular and
microbiological methods showed that they were representatives of a
single strain, had reduced susceptibility to vancomycin, did not react
with DNA probes specific for the enterococcal vanA or
vanB gene, and showed characteristics reminiscent of the
properties of a recently described vancomycin-resistant laboratory
mutant of Staphylococcus aureus. Cultures of these MRSE
isolates were heterogeneous: they contained
with a frequency of
10
4 to 10
5
bacteria for which vancomycin
MICs were high (25 to 50 µg/ml) which could easily be selected to
"take over" the cultures by using vancomycin selection in the
laboratory. In contrast, the five consecutive MRSE isolates recovered
from the PD patient during virtually continuous vancomycin therapy
showed no indication for a similar enrichment of more resistant
subpopulations, suggesting the existence of an "occult" infection
site in the patient (presumably at the catheter exit site) which was
not accessible to the antibiotic.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|